Right ventricular (RV) dysfunction is recognized as a major prognostic factor in left-sided heart failure (HF). However, the relative contribution of RV dysfunction in HF with preserved (HFpEF) vs. reduced ejection fraction (HFrEF) 
Introduction
Right ventricular (RV) dysfunction is recognized as a major prognostic factor in left-sided heart failure (HF), whether in the presence of preserved (HFpEF) or reduced ejection fraction (HFrEF).
1,2
Right ventricular dysfunction has been independently described in HFpEF and HFrEF cohorts, and has been found to be common and associated with worse prognosis.
3 -7 However, direct comparisons of RV function between HFpEF, HFrEF and controls from the same population are scarce.
Assessment of RV function by deformation imaging is a relatively new modality and has never been studied in relation to outcome in HFpEF. As with HFrEF, deformation or strain imaging may add prognostic value to more commonly used RV functional parameters. 8, 9 Right ventricular function is highly dependent on RV afterload.
10
Pulmonary hypertension is present in a large proportion of patients with HF and is independently associated with worse cardiovascular outcome. 3, 6 While the effect of pulmonary hypertension on outcome is similar for HFpEF and HFrEF, RV dysfunction appears to add independent prognostic information to pulmonary arterial pressure.
1,11
We compared the correlates and prognostic implications of RV dysfunction and RV-arterial coupling in a contemporary cohort of HFpEF, HFrEF and controls without HF, all prospectively recruited from the same population base, and assessed using comprehensive Doppler echocardiography and deformation imaging.
Methods

Study population
Patients with HFpEF and HFrEF were selected from the previously described Singapore Heart Failure Outcomes and Phenotypes (SHOP) study. 12 Briefly, SHOP is an Asian prospective observational multicentre study of patients hospitalized with a primary diagnosis of HF or attending a hospital clinic for the management of HF within 6 months of an episode of decompensated HF. HFpEF was defined as left ventricular ejection fraction (LVEF) ≥50% and HFrEF as LVEF <50%. Control subjects were recruited in parallel from the general population of Singapore through an ongoing epidemiologic study of aging (Singapore Longitudinal Aging Study, SLAS). Controls were free of coronary artery disease (CAD) or HF based on history and clinical examination, and free of major structural heart disease by echocardiography. HFrEF, HFpEF and control groups were age-and sex-matched (n = 219 per group). The primary endpoint was a composite of all-cause mortality and HF hospitalization.
Echocardiography
Comprehensive echocardiographic examinations were performed by trained echocardiographers according to the American Society of Echocardiography (ASE) guidelines. 13 Analyses were performed by technicians blinded to clinical information. The LVEF was quantified using the biplane method of disks from apical four-and two-chamber velocity ratio (E/e'). Left atrial volume index (LAVI) normalized for body surface area was obtained using the biplane area-length method. Right ventricular function and pulmonary pressures were assessed according to the ASE recommendations. 13 Tricuspid annular plane systolic excursion (TAPSE) was tracked in the apical four-chamber view using M-mode echocardiography. Pulmonary artery systolic pressure (PASP) was calculated as 4*[peak velocity of tricuspid regurgitation (TR)] 2 + estimated right atrial pressure based on inferior vena cava diameter and collapsibility. For survival analysis, PASP of 25 mmHg was approximated when no TR signal was present, and right atrial pressure of 5 mmHg when the inferior vena cava was not visualized. The pulmonary capillary wedge pressure (PCWP) was estimated by 1.24*(E/e') + 1.9. Mean pulmonary artery pressure (MPAP) was calculated as 90 -0.62*pulmonary artery acceleration time, with a lower limit of 12 mmHg. Pulmonary vascular resistance (PVR) was estimated using 10*(peak TR velocity/RV outflow tract time-velocity integral) + 0.16. Speckle tracking analysis was performed on two-dimensional images acquired at a frame rate of 60-80 Hz using EchoPac software (version 113, revision 1.2, GE Healthcare, Chicago, IL). Measurement of LV global longitudinal strain (GLS), computed using Automated Function Imaging taking the average of peak longitudinal strain in apical four-chamber, two-chamber, and long-axis views, was feasible in 203 controls, 159 patients with HFpEF and 165 patients with HFrEF. Right ventricular longitudinal strain (RVLS) and strain rate were derived by tracking the RV free wall in the apical four-chamber view. Based on RV visibility and image quality, RVLS was obtained in 182 control, 155 HFpEF and 158 HFrEF subjects. RVLS and LV GLS are negative values, where a lower (more negative) value indicates better function.
Statistical analysis
Data are presented as mean ± standard deviation for quantitative variables and frequency/percentage for qualitative variables. Exploratory analyses were performed with Student's t-test, ANOVA, Pearson's chi-square test and log-rank test, depending on the nature of data. Confirmatory analysis concerning the identification of correlates of RV dysfunction was carried out with a generalized structural equation model. 14 The variables of interest were selected a priori on the basis of published data and clinical relevance and included age, sex, body mass index (BMI), heart rate, mean arterial pressure, CAD, smoking, diabetes, hypertension, atrial fibrillation (AF), haemoglobin, LVEF, LAVI, E/e' and PASP. A backward elimination with removal probability fixed at ≥0.05 was applied for model selection, with the final model's precision adjusted with a robust procedure. A Cox regression model, complemented with Kaplan-Meier curves, was constructed for analysing the time to composite events (all-cause death or HF hospitalization) with age, sex, BMI, AF, average E/e', LVEF, diabetes, hypertension, CAD and estimated glomerular filtration rate considered. All cut-offs were identified with ROC curves. Statistical analyses were done using SPSS v21 and Stata MP v14, and performed at the 5% level of significance.
Results
Characteristics of the study population
Demographic and clinical characteristics of the 657 subjects are summarized in Table 1 . The study population had an average age of 66 ± 11 years, 50.1% were female; 67% were Chinese, 24% Malay, and 9% Indian. Patients with HFpEF had higher BMI compared to controls and HFrEF (27.7 ± 6, 25.0 ± 4 and 25.5 ± 5 kg/m 2 , Data are presented as mean ± standard deviation or n (%). ACE, angiotensin-converting enzyme; AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; eGFR, estimated glomerular filtration rate; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; MAP, mean arterial pressure; NA, not applicable; NYHA, New York Heart Association; NT-proBNP, N-terminal pro-B-type natriuretic peptide. Between-group comparisons were performed using ANOVA or Pearson's chi-square test: * P < 0.05 vs control, † P < 0.05 vs. HFpEF.
respectively). Hypertension and AF were more prevalent in HFpEF (87% and 31%) compared with HFrEF (71% and 23%), while CAD was more frequent in HFrEF (HFpEF vs. HFrEF: 35% vs. 57%). New York Heart Association class III or IV symptoms were reported by 14% of patients with HFpEF and by 18% of patients with HFrEF and higher NT-proBNP levels were detected in HFrEF compared with HFpEF (5435 ± 6866 vs. 2015 ± 3265 pg/mL).
Echocardiographic characteristics
Echocardiographic characteristics are summarized in Data are presented as mean ± standard deviation. A, late diastolic transmitral flow velocity; E, early diastolic transmitral flow velocity; E/e', early diastolic transmitral flow velocity to averaged annular early diastolic velocity ratio; FAC, fractional area change; GLS, global longitudinal strain; HFpEF, heart failure with preserved ejection fraction; HFrEF, heart failure with reduced ejection fraction; LAVI, left atrial volume index; LV, left ventricular; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; LVESD, left ventricular end-systolic dimension; MPAP, mean pulmonary artery pressure; PASP, pulmonary artery systolic pressure; PCWP, pulmonary capillary wedge pressure; PVR, pulmonary vascular resistance; RV, right ventricular; RVLS, right ventricular longitudinal strain; S', annular systolic velocity; TAPSE, tricuspid annular plane systolic excursion; TR, tricuspid regurgitation. Between-group comparisons were performed using ANOVA: * P < 0.05 vs control, † P < 0.05 vs HFpEF.
59% in HFpEF and 31% in HFrEF. Likewise, LV GLS increased (less negative) across groups from controls to HFpEF and HFrEF (−16.6 ± 2.6%, −14.5 ± 4.0%, and −7.4 ± 7.3%, respectively). Compared to controls, patients with HFpEF had similar LV chamber size but significantly increased left atrial dimensions. Left ventricular diastolic function, determined by E/A and E/e', was impaired in HFpEF, but more so in HFrEF.
Right ventricular function deteriorated across groups, whether assessed by RVLS, TAPSE, RV annular systolic velocity (S'), or fractional area change ( Table 2) . Approximately 30-40% of patients with HFpEF had RV dysfunction (TAPSE <17 mm or RVLS > −20%) compared with ≥60% of patients with HFrEF. PASP increased progressively across groups from controls to HFpEF and HFrEF patients (26.8 ± 7.1, 34.5 ± 11.9, and 39.3 ± 16.2 mmHg, respectively) (all P < 0.001), as did MPAP, PVR and PCWP. Pulmonary hypertension, defined as PASP >35 mmHg, was present in 39% of patients with HFpEF and 52% of patients with HFrEF. Controlling for PASP, RVLS/PASP and TAPSE/PASP ratios similarly decreased across groups ( Table 2) . A weak correlation was observed between PASP and TAPSE among controls (r = 0.22, P = 0.003) and HFpEF (r = 0.22, P = 0.01), but not in HFrEF (r = −0.07, P = 0.41). There were no significant correlations between PASP and RVLS in controls (r = −0.15, P = 0.060), HFpEF (r = −0.051, P = 0.60) and HFrEF (r = 0.13, P = 0.16). Table 3 shows the independent correlates of RV systolic dysfunction (reduced TAPSE or higher RVLS) in all patients with HF. Greater RV systolic dysfunction was independently associated with lower LVEF and AF but not with PASP. The presence of CAD was independently associated with greater RV dysfunction by TAPSE. A history of hypertension was independently related to better RV systolic function by RVLS (more negative RVLS). Hypertensive patients with HF had higher LVEF compared with patients without hypertension (46% vs. 39%, P = 0.002). To ascertain if there was an association between RV and ventricular septal function, septal S' was entered into the optimised models for TAPSE and RVLS displayed in Table 3 . Septal S' was independently associated with TAPSE (P < 0.001) but not with RVLS (P = 0.82).
Independent correlates of right ventricular dysfunction
Right ventricular dysfunction and prognosis
Patients were followed for a median of 715 days. During follow-up, 63 patients (9.6% of the total population) died, of whom 25 had HFpEF (11.4%) and 35 had HFrEF (16%). A total of 176 patients suffered the primary endpoint (16.7%), of whom 76 had HFpEF (34.7%) and 98 HFrEF (44.7%) (Figure 1 ) (log-rank P = 0.017 for HFpEF vs. HFrEF).
In unadjusted analyses of patients with HF regardless of LVEF, both PASP and TAPSE, but not RVLS and RV strain rate, were related to the composite endpoint ( Table 4) . When adjusted for putative risk predictors, RVLS was independently associated with this outcome, whereas PASP and TAPSE were not. TAPSE and RVLS normalized for afterload as TAPSE/PASP and RVLS/PASP ratios, respectively, were both significantly related to the composite endpoint, even after multivariable adjustment [hazard ratio (HR) 0.33; 95% confidence interval (CI) 0.14-0.74 and HR 3.09; 95% CI 1.52-6.26, respectively]. These relationships were similar in both HF groups (P for interaction with HF group, TAPSE: 0. Figure 2 displays survival curves, which depict a significant increase in the composite endpoint among patients with HF with TAPSE <14 mm (log-rank P = 0.01), TAPSE/PASP <0.48 (log-rank P < 0.001) and RVLS/PASP ≥ −0.56 (log-rank P < 0.001).
Sensitivity analyses
PASP was not obtainable in 163 subjects (24 controls, 77 HFpEF, 62 HFrEF). Baseline clinical characteristics of subjects with and without PASP measurements showed no differences in age (66 vs. 65 years, P = 0.06), sex (50% female gender in both groups), prevalence of hypertension (64% vs. 72%, P = 0.06), or CAD (29% vs. 33%, P = 0.37). Subjects in whom PASP was not measurable had on average higher BMI (27.2 vs. 25.7 kg/m 2 , P = 0.002), a higher prevalence of diabetes (52% vs. 40.5%, P = 0.006) and were less often in AF (9% vs. 20%, P = 0.012) compared with subjects with PASP measurements. Survival analyses restricted to patients with measurable PASP revealed similar prognostic associations for TAPSE/PASP (adjusted HR 0.27; 95% CI 0.10-0.74, P = 0.011) and RVLS/PASP (adjusted HR 2.96; 95% CI 1.34-6.56, P = 0.007).
Discussion
We provide data on RV function in HFpEF vs. HFrEF, referenced to a control group without HF, all prospectively recruited from a multi-ethnic Asian population using a standardized protocol. The prevalence of RV dysfunction, assessed by TAPSE and RV deformation imaging, was up to 42% in HFpEF, four times that of controls, and even higher in HFrEF, occurring in two-thirds of patients. The presence of RV dysfunction was independently associated with concomitant LV dysfunction but not with PASP, suggesting the contribution of shared biventricular myocardial processes to RV dysfunction in HF. We also find that RV-arterial coupling was prognostically important in HF regardless of LVEF.
Right ventricular deformation imaging in heart failure with preserved ejection fraction
To our knowledge, there has been only one published study on RV deformation imaging in HFpEF-this found more impaired RV strain and diastolic strain rate in HFpEF compared with asymptomatic LV diastolic dysfunction. 15 Because RVLS was derived by averaging RV free wall and interventricular septal strain, there could be confounding by LV function on account of the common septum. There are no prior reports on RVLS of the free wall in HFpEF and no reports describing RV strain in relation to outcome. The present study also reports RV strain in a relatively large group of controls without overt CAD or HF. A recent meta-analysis involving 486 normal subjects reported an average RVLS of −27 ± 2%, similar to our results (−26.8 ± 5%). 16 The mean LV GLS (−13.8 ± 5%) in our study is in line with previous findings in patients with HFpEF. 
Concomitant left and right ventricular dysfunction in heart failure
The association of RV dysfunction with LVEF, AF, CAD and hypertension observed in this study is consistent with previous findings. 2, 5, 7, 18 There could be several explanations for parallel LV and RV dysfunction in HF patients. In the "helical ventricular myocardial band" model proposed by Torrent-Guasp, the right and left ventricles are encircled by transversely oriented circular myocardial fibres within a basal loop while reciprocally wound oblique fibres, comprising a right-handed arm within the subendocardial muscle and a left-handed arm in the subepicardial muscle, criss-cross within the interventricular septum and connect in an apical helix. 19 The cross-striation of oblique fibres within the ventricular septum enhances septal twisting motion and augments both RV and LV function. 20 In addition to the complex myocardial fibre organization, alterations in LV configuration, loading and function can influence RV contractility via systolic and diastolic ventricular interactions, mediated through the shared ventricular septum. This putative mechanism is supported by the independent . . . Cox proportional hazard models for the composite endpoint of all-cause mortality and heart failure hospitalization in patients with heart failure with preserved or reduced ejection fraction. Variables adjusted for include age, sex, body mass index, atrial fibrillation, average E/e', left ventricular ejection fraction, diabetes, hypertension, coronary artery disease and estimated glomerular filtration rate. CI, confidence interval; HR, hazard ratio; PASP, pulmonary artery systolic pressure; RV, right ventricular; RVLS, right ventricular longitudinal strain; TAPSE, tricuspid annular plane systolic excursion. * P < 0.05. association between septal S' and TAPSE. Coronary artery disease was also frequent in both HFpEF and HFpEF, and can lead to LV and RV ischaemia or infarction. Additionally, neurohumoral activation in left-sided HF can have direct or indirect effects on RV function. Pulmonary hypertension may further compromise the right ventricle, which is sensitive to increases in afterload. However, PASP was not an independent predictor of RV function in our HF cohort, for reasons discussed later. A history of hypertension was related to enhanced (more negative) RVLS, consistent with another study showing a positive correlation between systolic blood pressure and TAPSE. 18 The higher LVEF among HF patients with hypertension may be explanatory, underscoring the nexus between LV and RV systolic function, but direct effects of antihypertensive drug therapy on RV function 21 or confounding by hypotensive agents in HF patients with biventricular dysfunction are other possibilities.
The parallel and progressive gradient of RV and LV dysfunction from controls to HFpEF and HFrEF which we consistently demonstrated, irrespective of the index measured, suggests that, in our 
Right ventricular dysfunction as a prognostic marker
The composite endpoint was attained less frequently in patients with HFpEF than with HFrEF (35% vs. 45%), with a higher mortality rate in HFrEF as previously reported. 18 Of the RV function parameters, PASP and RVLS, but not TAPSE, were related to the composite endpoint in adjusted analysis. To our knowledge, the predictive value of RV deformation imaging has never been studied in HFpEF. Both TAPSE and RVLS quantify longitudinal RV function, which accounts for the majority of RV contraction vis-à-vis transverse shortening. However, TAPSE is a regional parameter, measuring tricuspid annular shortening towards the RV apex, is angle-dependent and unreliable in the postoperative setting. 23 
Right ventricular-pulmonary arterial coupling
The relationship between PASP and RV dysfunction has previously been examined, with conflicting results in patients with HFpEF. 2, 5 Although univariately significant associations have been reported for mixed HFrEF and HFpEF cohorts 11, 24 , one large study of 1547 patients found that PASP, when measurable, was not independently predictive of TAPSE, whether in HFpEF or all patients.
18
Likewise, PASP was not independently associated with TAPSE in a study on HFrEF. 25 We observed no significant correlation between PASP and both TAPSE and RVLS in HFrEF and only a weak correlation with TAPSE in patients with HFpEF. PASP was not independently associated with TAPSE or RVLS among all or either subset of patients with HF. These findings may be explained by the recognized biphasic response of RV function to increasing PASP. Changes in RV afterload (and preload) can lead to increased RV contractility via heterometric autoregulation (Starling's law), and when acute and sustained, are associated with a homeometric contractility adpatation (Anrep's law). 26 When this adaptation fails for any reason, there is RV-pulmonary arterial "uncoupling". Right ventricular-pulmonary arterial uncoupling occurs in patients with type I pulmonary arterial hypertension with severely elevated PASP, and in pacing-induced tachycardiomyopathy where pulmonary hypertension is mild but RV contractility markedly depressed. 27 Right ventricular-pulmonary arterial uncoupling would be expected in decompensated HFrEF, 28 but Andersen et al. reported that (partially reversible) pulmonary vasoconstriction in early stage HFpEF can lead to RV systolic and diastolic dysfunction in the absence of RV structural remodelling. 29 These functional changes could well occur in our patients with HFpEF who, similar to theirs, had mild pulmonary hypertension and minimally increased PVR on average.
Since PASP was a predictor of the composite endpoint and RV function is sensitive to afterload, we used the ratios of TAPSE and RVLS to PASP as surrogates of the RV-pulmonary arterial coupling relationship, as others have proposed.
1,11 Both TAPSE/PASP and RVLS/PASP ratios were significantly related to outcome, even after multivariable adjustment.
Study limitations
The current study was performed using echocardiography, whereas cardiac magnetic resonance imaging is considered the gold standard for RV functional assessment. The right ventricle was not optimally visualized in all cases, resulting in missing data. However, echocardiography remains by far the most accessible tool to characterise RV function in large numbers of patients in clinical practice. Not all RV function parameters such as right atrial area and diastolic function were assessed. Haemodynamic data (PCWP, PASP, MPAP, PVR) were calculated from echocardiographic parameters and not obtained invasively. While these non-invasive estimates correlate highly with invasive measurements in advanced HFrEF, 30 their utility in HFpEF is uncertain.
Conclusions
Right ventricular dysfunction, as assessed by TAPSE and RV deformation imaging, was more prevalent in HFpEF compared to controls, and in HFrEF compared to both controls and HFpEF. The presence of RV dysfunction was related to and parallels coexistent LV dysfunction, and not to PASP per se. In aggregate, our findings indicate that RV dysfunction is not simply a sequela of increased afterload consequent to LV dysfunction and passive congestion, but a more complex pathophysiological accompaniment of left-sided HF regardless of LVEF, involving ventricular interdependence and possibly common biventricular myocardial processes. Thus, future interventions directed at RV dysfunction in HF should have the potential to improve global systolic function of both ventricles, with the left ventricle being a prime therapeutic target. abnormal RV-arterial coupling was associated with adverse prognosis in left-sided HF regardless of LVEF.
